SUGAR LAND REHAB HOSPITAL — History
CCN 673068 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+41.2%
Revenue CAGR (3yr)
61.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $10M | $11M | $20M | +75.3% | +41.2% |
| Operating Expenses | $10M | $10M | $8M | -26.0% | -12.4% |
| Operating Margin | -0.3% | 8.4% | 61.4% | +627.6% | +0.0% |
| Net Income | $-0M | $1M | $12M | +1175.5% | +0.0% |
| Licensed Beds | 41 | 41 | 41 | +0.0% | +0.0% |
| Total Patient Days | 6,194 | 6,713 | 9,407 | +40.1% | +23.2% |
| Medicare Day % | 76% | 76% | 73% | -2.9% | -1.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +99.3% ($10M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+41.2%
This Hospital
+7.6%
State Avg
Latest Margin
61.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $24M | 92.2% |
| FY2024 (proj) | $29M | 123.1% |
| FY2025 (proj) | $34M | 153.9% |